ArticleVaccines2026
Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2.
Auchara Tangsathapornpong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.